8RUU

Fabs derived from bimekizumab in complex with IL-17F

• PDB DOI: https://doi.org/10.2210/pdb8RUU/pdb

• Classification: IMMUNOSUPPRESSANT
• Organism(s): Homo sapiens
• Expression System: Cricetulus griseus
• Mutation(s): No 


• Deposited: 2024-01-31 Released: 2024-04-24 
• Deposition Author(s): Adams, R., Lawson, A.D.G.
• Funding Organization(s): Not funded

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.81 Å
• R-Value Free: 0.241 
• R-Value Work: 0.204 
• R-Value Observed: 0.206 

Literature

Crystal Structure of Bimekizumab Fab Fragment in Complex with IL-17F Provides Molecular Basis for Dual IL-17A and IL-17F Inhibition.

Adams, R., Bunick, C.G., Lawson, A.D.G., Gomez, B., Shaw, S.

(2024) J Invest Dermatol 144: 2581

• PubMed: 38631666 
• DOI: https://doi.org/10.1016/j.jid.2024.03.037
• Primary Citation of Related Structures:  
  8RUU

---

Organizational Affiliation: 

UCB Pharma, Slough, United Kingdom. Electronic address: [e-mail].

Biological Assembly 1  

Global Symmetry: Cyclic - C2  (Explore in 3D)
Global Stoichiometry: Hetero 6-mer - A2B2C2 

Biological assembly 1 assigned by authors and generated by PISA (software)

Biological Assembly Evidence: gel filtration

Macromolecule Content

• Total Structure Weight: 127.28 kDa 
• Atom Count: 8,323 
• Modelled Residue Count: 1,064 
• Deposited Residue Count: 1,150 
• Unique protein chains: 3

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Immunoblobulin heavy chain	A [auth B], D [auth H]	228	Homo sapiens	Mutation(s): 0

Entity ID: 2
Molecule	Chains	Sequence Length	Organism	Details	Image
Immunoblobulin light chain	B [auth C], E [auth L]	214	Homo sapiens	Mutation(s): 0

Entity ID: 3
Molecule	Chains	Sequence Length	Organism	Details	Image
Interleukin-17F	C [auth X], F [auth Y]	133	Homo sapiens	Mutation(s): 0  Gene Names: IL17F
UniProt & NIH Common Fund Data Resources
Find proteins for Q96PD4 (Homo sapiens) Explore Q96PD4  Go to UniProtKB:  Q96PD4
PHAROS:  Q96PD4 GTEx:  ENSG00000112116
Glycosylation
Glycosylation Sites: 1		Go to GlyGen: Q96PD4-1

Oligosaccharides

Help

Entity ID: 4
Molecule	Chains	Length	2D Diagram	Glycosylation	3D Interactions
alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose	G [auth A]	5		N-Glycosylation
Glycosylation Resources
GlyTouCan:  G26551VB GlyCosmos:  G26551VB GlyGen:  G26551VB

Small Molecules

Ligands 1 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram
NAG	H [auth Y]	2-acetamido-2-deoxy-beta-D-glucopyranose C8 H15 N O6 OVRNDRQMDRJTHS-FMDGEEDCSA-N

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.81 Å
• R-Value Free: 0.241 
• R-Value Work: 0.204 
• R-Value Observed: 0.206 
• Space Group: P 2₁ 2₁ 2₁

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 99.15	α = 90
b = 141.75	β = 90
c = 145.56	γ = 90

Software Package:

Software Name	Purpose
PHENIX	refinement
PHASER	phasing
xia2	data scaling
XDS	data reduction

Structure Validation

Entry History & Funding Information

Deposition Data

• Released Date: 2024-04-24 
Deposition Author(s): Adams, R., Lawson, A.D.G.

---

Funding Organization	Location	Grant Number
Not funded		--

Revision History  

• Version 1.0: 2024-04-24
  Type: Initial release
  
• Version 1.1: 2024-05-01
  Changes: Database references
• Version 1.2: 2024-10-23
  Changes: Structure summary
• Version 1.3: 2024-11-06
  Changes: Database references